PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Republic of Korea.\', \'Medical Laboratory Sciences Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'Special Infectious Agents Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'Enzymoics, Novel Global Community Educational Foundation, Hebersham, Australia.\', \'Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'Department of Biochemistry, University of Allahabad, Prayagraj, India.\', \'Center for Bioinformatics, Computational and System Biology, Pathfinder Research and Training Foundation, Greater Noida, India.\', \'Department of Physics, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/07391102.2020.1842807
?:doi
?:hasPublicationType
?:journal
  • Journal of biomolecular structure & dynamics
is ?:pmid of
?:pmid
?:pmid
  • 33150855
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33150855>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33150855>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all